RxDoctor Payments Data

Holly Bennett

Adult Health · Galloway, NJNPI 1861784423

Payments from drug & device makers

$735in general payments, 2019–2025

Across 31 payments — averaging $23.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$133
  • Coloplast$131
  • Medtronic$109
  • Exact Sciences$58
  • Novo Nordisk$47
  • GSK$47
  • plus $210 from 9 others

What the payments were for

  • Food & beverage$735100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$735 in reported general payments places this provider in the 60th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$84,917
Medicare patients
313
Services billed
1,294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate47$52,997
MounjaroTirzepatide28$33,622
EliquisApixaban25$28,066
OzempicSemaglutide23$27,949
MyrbetriqMirabegron24$25,223
JardianceEmpagliflozin21$21,205
Janumet XrSitagliptin Phos/Metformin Hcl13$15,327
GemtesaVibegron15$9,765
Fluticasone-SalmeterolFluticasone Propion/Salmeterol28$6,791
Atorvastatin Calcium416$5,065
SynthroidLevothyroxine Sodium52$4,146
VascepaIcosapent Ethyl12$3,924
NexiumEsomeprazole Magnesium11$2,952
Omeprazole197$2,737
Levothyroxine Sodium273$2,734

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet Xr$20$68,32460 claims
Lilly USA, LLCMounjaro$17$33,62228 claims
PfizerEliquis$29$28,06625 claims
Novo NordiskOzempic$47$27,94923 claims
AstraZenecaNexium$32$2,95211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Galloway

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →